Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05842161 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

South Africa Smoking Cessation and Engagement in HIV/TB Care Care

StatusRecruiting
PhaseNot applicable
Started2024-03-12
View on ClinicalTrials.gov ↗
The purpose of this study is to integrate elements from existing interventions developed by our team into a single intervention (QUIT-AD), designed to improve smoking cessation and favorable HIV/TB treatment outcomes among individuals with HIV and/or TB in Cape Town, South Africa. If feasibility, acceptability, and preliminary efficacy are demonstrated, the intervention will be ready for large-scale effectiveness/implementation testing. This program will has the potential to dramatically improve public health by increasing the smoking quit rate and facilitating favorable HIV/TB treatment outcomes among patients with HIV and/or TB in resource limited South African settings.

Amendment history 2 changes detected by DataLookout

2026-09-10
Primary completion pushed: 2026-05-01 → 2027-05-01
2026-09-10
Completion pushed: 2026-05-31 → 2027-05-31
Trial Details
NCT Number NCT05842161
Lead Sponsor Massachusetts General Hospital
Collaborators: Boston University, University of Cape Town, National Institute on Drug Abuse (NIDA)
Conditions HIV Infections, Tuberculosis, Smoking Cessation
Enrollment 83 participants
Start Date 2024-03-12
Primary Completion 2027-05-01 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-09